Revenio Group Oyj (OTCMKTS:REVXF – Get Free Report) saw a large growth in short interest in May. As of May 29th, there was short interest totaling 12,217 shares, a growth of 5,530.0% from the May 14th total of 217 shares. Based on an average daily volume of 430 shares, the short-interest ratio is presently 28.4 days.
Revenio Group Oyj Stock Performance
Shares of REVXF remained flat at $16.41 during midday trading on Tuesday. The business’s 50-day moving average price is $18.45 and its 200 day moving average price is $21.43. Revenio Group Oyj has a 12-month low of $16.41 and a 12-month high of $16.54.
About Revenio Group Oyj
Revenio Group Oyj is a Finland‐based medical technology company specializing in ophthalmic diagnostic instruments. The company’s core business centers on the design, manufacture and sales of intraocular pressure (IOP) measurement devices that support glaucoma screening, diagnosis and long‐term patient monitoring. Utilizing patented rebound tonometry technology, Revenio’s tonometers provide rapid, non-invasive IOP readings without the need for topical anesthesia, making them well‐suited for both clinical and home settings.
Revenio’s product portfolio is anchored by the Icare® family of tonometers, which includes the Icare PRO for clinical use and the Icare HOME for patient self-monitoring.
Featured Articles
- Five stocks we like better than Revenio Group Oyj
- The Bank of Mom and Dad Is Booming—3 Stocks to Watch
- Corning Is Paving AI’s Future With Glass
- Why’s Amazon Suddenly Lagging the S&P 500, and Is It a Warning?
- Crypto Winter Is Here: 3 Stocks To Put On Ice This Summer
Receive News & Ratings for Revenio Group Oyj Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revenio Group Oyj and related companies with MarketBeat.com's FREE daily email newsletter.
